Gender differences in the prevalence and clinical correlates of thyroid dysfunction in patients with first-episode and drug-naïve major depressive disorder with comorbid suicide attempts: a large cross-sectional study
- PMID: 37596572
- PMCID: PMC10436425
- DOI: 10.1186/s12888-023-05089-w
Gender differences in the prevalence and clinical correlates of thyroid dysfunction in patients with first-episode and drug-naïve major depressive disorder with comorbid suicide attempts: a large cross-sectional study
Abstract
Background: Gender differences in patients with major depressive disorder (MDD) are commonly reported; however, gender differences in first-episode and drug-naïve (FEDN) MDD patients with comorbid suicide attempts have not been reported. This study aimed to examine potential gender differences in the prevalence and clinical correlates of comorbid abnormal thyroid function (ATF) in FEDN MDD patients with comorbid suicide attempts.
Methods: A cross-sectional study of 1718 FEDN MDD patients was conducted. The demographic and clinical data were collected. The Hamilton Depression Scale (HAMD), the Hamilton Anxiety Scale (HAMA) and Positive and Negative Syndrome Scale (PANSS) were used to assess depression, anxiety and psychotic symptoms, respectively. Thyroid function parameters and blood glucose levels were measured.
Results: There was no gender difference in the prevalence of ATF between male (78.6%, 88/112) and female MDD patients (74.8%, 175/234) with comorbid suicide attempts. In the male and female subgroups, duration of disease, HAMD score, HAMA score, anti-thyroglobulin (TgAb), thyroid peroxidases antibody (TPOAb), diastolic blood pressure (DBP), systolic blood pressure (SBP), glucose level and the rate of psychotic symptoms were higher in patients with ATF than those without ATF in MDD with comorbid suicide attempt (all P < 0.05). There was a gender main effect only on SBP (F = 7.35, P = 0.007). Furthermore, binary logistic regression analysis showed that HAMD score, DBP and glucose levels were independently with ATF in both male and female MDD patients with comorbid suicide attempts. However, anxiety symptoms, psychotic symptoms and TPOAb levels were significantly associated with ATF only in female MDD patients with comorbid suicide attempts.
Conclusion: Our study showed no gender differences in the prevalence of ATF in FEDN MDD patients with comorbid suicide attempts. Depression, DBP and glucose levels were associated with ATF in both male and female MDD patients with comorbid suicide attempts, whereas anxiety, psychotic symptoms and TPOAb level were correlated with ATF only in female MDD patients with suicide attempts.
Keywords: Abnormal thyroid function; Gender; Major depressive disorder; Suicide.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Prevalence and clinical profile of abnormal glucose in first-episode and drug-naïve patients with major depressive disorder with comorbid abnormal thyroid function: a large-scale cross-sectional study.BMC Psychiatry. 2023 May 24;23(1):362. doi: 10.1186/s12888-023-04842-5. BMC Psychiatry. 2023. PMID: 37226146 Free PMC article.
-
Clinical correlates, lipid metabolic parameters and thyroid hormones are associated with abnormal glucose metabolism in first-episode and drug-naïve major depressive disorder patients with suicide attempts: A large cross-sectional study.J Affect Disord. 2025 Jul 1;380:10-16. doi: 10.1016/j.jad.2025.03.102. Epub 2025 Mar 20. J Affect Disord. 2025. PMID: 40120949
-
Metabolic parameters and thyroid hormones in relation to suicide attempts in patients with first-episode and drug-naive major depressive disorder with comorbid glucose disturbances: a large cross-sectional study.Eur Arch Psychiatry Clin Neurosci. 2023 Feb;273(1):199-207. doi: 10.1007/s00406-022-01490-w. Epub 2022 Sep 20. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 36127506
-
The association of clinical correlates, metabolic parameters, and thyroid hormones with suicide attempts in first-episode and drug-naïve patients with major depressive disorder comorbid with anxiety: a large-scale cross-sectional study.Transl Psychiatry. 2021 Feb 4;11(1):97. doi: 10.1038/s41398-021-01234-9. Transl Psychiatry. 2021. PMID: 33542178 Free PMC article.
-
Prevalence and risk factors for abnormal glucose metabolism in first-episode and drug-naïve major depressive disorder outpatients with comorbid anxiety: A cross-sectional study from a large sample of the Chinese Han population.J Affect Disord. 2024 Mar 15;349:400-406. doi: 10.1016/j.jad.2024.01.014. Epub 2024 Jan 8. J Affect Disord. 2024. PMID: 38199404
Cited by
-
Exploring Gender Differences in the Relationship Between Thyroid Function and Aggressive and Impulsive Behaviors in Patients with Major Depressive Disorder.Neuropsychiatr Dis Treat. 2025 Mar 14;21:563-574. doi: 10.2147/NDT.S510936. eCollection 2025. Neuropsychiatr Dis Treat. 2025. PMID: 40103619 Free PMC article.
-
Prevalence and risk factors for subclinical hypothyroidism in older patients with major depressive disorder.BMC Geriatr. 2024 Jan 4;24(1):15. doi: 10.1186/s12877-023-04584-9. BMC Geriatr. 2024. PMID: 38177993 Free PMC article.
References
-
- Han KM, Kim MS, Kim A, Paik JW, Lee J, Ham BJ. Chronic medical conditions and metabolic syndrome as risk factors for incidence of major depressive disorder: a longitudinal study based on 4.7 million adults in South Korea. J Affect Disord. 2019;257:486–494. doi: 10.1016/j.jad.2019.07.003. - DOI - PubMed
-
- Stegenga BT, King M, Grobbee DE, Torres-González F, Švab I, Maaroos HI, Xavier M, Saldivia S, Bottomley C, Nazareth I, Geerlings MI. Differential impact of risk factors for women and men on the risk of major depressive disorder. Ann Epidemiol. 2012;22(6):388–396. doi: 10.1016/j.annepidem.2012.04.011. - DOI - PMC - PubMed
-
- Ganança L, Galfalvy HC, Cisneros-Trujillo S, Basseda Z, Cooper TB, Ren X, Figueira ML, Oquendo MA, Mann JJ, Sublette ME. Relationships between inflammatory markers and suicide risk status in major depression. J Psychiatr Res. 2021;134:192–199. doi: 10.1016/j.jpsychires.2020.12.029. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources